FIVE PRIME THERAPEUTICS, INC. 4/A SEC Filings

Filed On	Filing
04 Apr 2019	Form 4/A: Irving Bryan, EVP, Chief Scientific Officer Received 3,750 shares as a grant or award · Granted 22,500 Employee Stock Option (right to buy)
28 Feb 2019	Form 4/A: Williams Lewis T, Director Received 1,000 shares as a grant or award · Granted 6,400 Employee Stock Option (right to buy)
13 Feb 2018	Form 4/A: Williams Lewis T, Director Gave 0 shares as a gift
13 Feb 2018	Form 4/A: Williams Lewis T, Director Gave up 32,613 shares to cover exercise price or tax ($1.46M) · Gave 22,416 shares as a gift

Comments